Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods
T. Ginez, U. Garaigorta, D. Ramirez, V. Castro, V. Nozal, I. Maestro, J. Garcia-Carceles, N. E. Campillo, A. Martinez, P. Gastaminza, C. Gil
The paper identifies five FDA-approved drugs with antiviral activity against SARS-CoV-2 using a combined in silico and in vitro screening approach.
bioRxiv · Nov 26, 2020Microbiology